Status:
SUSPENDED
Laser Assisted ICSI; Has it Role Whatsoever?
Lead Sponsor:
Royal Fertility Center, Egypt
Conditions:
Laser Assistance to Improve ICSI Outcome
Eligibility:
FEMALE
20-37 years
Phase:
NA
Brief Summary
laser-assisted ICSI (LA-ICSI) was described to be a new method combining a less invasive ICSI technique with assisted hatching.This procedure is usually used for MII oocytes possessing oolemma breakag...
Detailed Description
This study aims to compare the LA- ICSI by drilling a micro hole (LAD-ICSI) and modified LA-ICSI by zona pellucida thinning (LAT-ICSI) with conventional ICSI in order to effectively assess whether thi...
Eligibility Criteria
Inclusion
- Patients aged from 20 years old to 37 years old
- good res-ponders
- gives more than 15 oocytes
- endometrial thickness more than 9 mm
Exclusion
- poor res-ponders
- severe oligoasthinozoospermia of male partners
- testicular samples
- Poor quality oocytes
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04455412
Start Date
February 1 2020
End Date
January 1 2024
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Fertility Center
Al Mansurah, Dakahlia Governorate, Egypt, 12111